Bococizumab is a novel anti-PCSK9 antibody specifically developed to address hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a essential regulator of cholesterol levels. By neutralizing https://roxannbger614694.wikiexpression.com/user